Feature|Articles|August 17, 2026

Competing Vaccine Schedules Leave Pharmacists Navigating Confusion

A year of ACIP turnover, schedule changes, and lawsuits has fractured US vaccine guidance—and tied pharmacists' scope and billing to a moving target.

For more than 60 years, the Advisory Committee on Immunization Practice (ACIP), a committee of scientific and health experts, has driven federal vaccine recommendations later adopted by the CDC.¹ Since United States Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr was sworn in on February 13, 2025, that process has been upended through committee turnover, unilateral recommendation changes, ongoing litigation, and, most recently, competing vaccine schedules from federal agencies and nonfederal medical societies alike.